Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders [Phase 4]
Phase 4 trial evaluating influenza vaccination to prevent flu in patients with plasma cell neoplasms has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies [Phase 2]
Phase 2 clinical trial update on shorter course tacrolimus after non-myeloablative conditioning with related donor PBSCT and high-dose postt…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial update for combination chemotherapy in treating patients with multiple myeloma and plasma cell neoplasm.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma [Phase 2]
Phase 2 trial updating combination chemotherapy, peripheral stem cell transplant, biological therapy, pamidronate, and thalidomide in multip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating activated white blood cells with autologous stem cell transplant for newly diagnosed multiple myeloma co…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma [EARLY_Phase 1]
Early-phase clinical trial evaluating interferon alfa and interleukin-6 in patients with recurrent multiple myeloma; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]
Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-ris…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of ANGEL, an EBV-specific cytotoxic T-cell therapy for relapsed Epstein…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis [Phase 2]
Phase 2 trial update evaluating a second autologous stem cell transplant in patients with persistent or recurrent AL amyloidosis, with resul…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports a completed Phase 1/2 study of arsenic trioxide plus vitamin C in patients with recurrent or refractory m…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating peripheral stem cell transplantation in adults with multiple myelo…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a regimen of bortezomib, pegylated liposomal doxorubicin (Doxil), and dexamethasone, with or without thali…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide plus rituximab in patients with recurrent or refractory multiple myeloma; the study was terminated wit…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of lenalidomide in combination with vaccine therapy for relapsed or refractory multiple myeloma has completed, with results po…